Blinded NO Subject Drug


Indications and Reactions:

Role Indications Reactions
Primary
Prostate Cancer 13.6%
Renal Cell Carcinoma 11.4%
Pain 8.6%
Acute Coronary Syndrome 7.1%
Hypertension 6.4%
Smoking Cessation Therapy 6.4%
Hepatic Cancer 5.7%
Hepatocellular Carcinoma 5.7%
Asthma 4.3%
Epilepsy 4.3%
Chronic Obstructive Pulmonary Disease 3.6%
Neuralgia 3.6%
Hepatic Neoplasm Malignant 2.9%
Hepatic Neoplasm Malignant Recurrent 2.9%
Insomnia 2.9%
Anxiety 2.1%
Cardiovascular Disorder 2.1%
Diabetes Mellitus 2.1%
Hypercholesterolaemia 2.1%
Prophylaxis 2.1%
Status Epilepticus 13.6%
Anal Abscess 4.5%
Angina Unstable 4.5%
Cholecystitis 4.5%
Depression Suicidal 4.5%
Foot Fracture 4.5%
Gallbladder Disorder 4.5%
General Physical Health Deterioration 4.5%
Hypertriglyceridaemia 4.5%
Lipase Increased 4.5%
Liver Abscess 4.5%
Myocardial Infarction 4.5%
Non-cardiac Chest Pain 4.5%
Osteitis 4.5%
Pyrexia 4.5%
Renal Failure 4.5%
Second Primary Malignancy 4.5%
Skin Exfoliation 4.5%
Small Intestinal Obstruction 4.5%
Subdural Haematoma 4.5%
Secondary
Rheumatoid Arthritis 19.2%
Osteoarthritis 17.2%
Prophylaxis 8.6%
Hypertension 7.9%
Smoking Cessation Therapy 5.9%
Peyronie's Disease 5.1%
Hypersensitivity 4.5%
Gastrooesophageal Reflux Disease 3.1%
Asthma 2.9%
Insomnia 2.8%
Acute Myocardial Infarction 2.7%
Hyperlipidaemia 2.7%
Cardiac Failure 2.6%
Depression 2.4%
Routine Health Maintenance 2.2%
Non-small Cell Lung Cancer 2.2%
Anxiety 2.1%
Pain 2.1%
Osteoporosis 2.0%
Breast Cancer 1.8%
Fracture Of Penis 9.9%
Migraine 7.4%
Grand Mal Convulsion 6.6%
Liver Function Test Abnormal 6.6%
Death 5.8%
Long Qt Syndrome 5.8%
Basal Cell Carcinoma 5.0%
Clostridium Difficile Colitis 5.0%
Dehydration 5.0%
Gastrooesophageal Reflux Disease 5.0%
Polymedication 5.0%
Renal Failure Acute 5.0%
Gallbladder Disorder 4.1%
Hypertriglyceridaemia 4.1%
Compression Fracture 3.3%
Coronary Artery Disease 3.3%
Drug Withdrawal Syndrome 3.3%
Fatigue 3.3%
Mental Status Changes 3.3%
Non-hodgkin's Lymphoma 3.3%

Drug Data